X4 PharmaceuticalsXFOR
13F holders, Q2 2026 (June 30)1holders −1
0new positions
1sold out
$4.67avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding X4 Pharmaceuticals Inc. (XFOR) in their 13F filings, down 1 from Q1 2026. 0 opened new positions and 1 sold out. The largest holder was NEA Management Company, LLC ($15.1M).
- Company
- X4 Pharmaceuticals Inc.
- CUSIP
- 98420X103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $967K |
All 13F filers, Q1 2026 → Q2 2026: 234,039 shares sold, net −234,039 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| NEA Management Company, LLC | 0.95% | No change | 3,233,743 | $15.1M |
"% of holder's portfolio" is XFOR's weight in each manager's 13F, not the share of X4 Pharmaceuticals Inc. the manager owns.